Eris Lifesciences Ltd. Conference Calls and Earnings Call Transcripts

23 Mar 2023

1675.80

3.57%

Earnings Call

Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

TRANSCRIPT OF CONFERENCE CALLSCHEDULED IN CONNECTION WITH THE ACQUISITION OF NINE DERMATOLOGY BRANDS FROM DR.REDDY'S LABORATORIES LTD

pdf

Eris Lifesciences Ltd.

16 Mar 2023

1675.80

3.57%

Earnings Call

Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Dear Sir/Madam, This is to inform that the Audio Recording of the Conference Call which was held on Thursday, 16 March 2023 in connection with the acquisition of nine dermatology brands from Dr. Reddy''s Laboratories Ltd., is available on the website of the Company and can be accessed through the following link: Link: https://eris.co.in/announcements-notices/ (File name: Conference call recording)

pdf

Eris Lifesciences Ltd.

16 Mar 2023

1675.80

3.57%

Eris Lifesciences Call on Brand Acquisitions from Dr. Reddy's

Conference Call with Eris Lifesciences Management and Analysts on the acquisitions of dermatology brands from Dr. Reddy's. Listen to the full earnings transcript.

audio

Eris Lifesciences Ltd.

23 Jan 2023

1675.80

3.57%

Earnings Call

Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Dear Sir/Madam, This is to inform that the transcript of the Analyst and Investor call which was held after the announcement of financial results for the quarter ended, 31st December 2022 is available on our website URL https://eris.co.in/financials/ (File name: Transcript of the Analyst and Investor Conference Call Q3FY23).

pdf

Eris Lifesciences Ltd.

17 Jan 2023

1675.80

3.57%

Results Earnings Call for Q3FY23 of Eris Lifesciences

Conference Call with Eris Lifesciences Management and Analysts on Q3FY23 Performance and Outlook. Listen to the full earnings transcript.

audio

Eris Lifesciences Ltd.

31 Oct 2022

1675.80

3.57%

Earnings Call

Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

TRANSCRIPT OF ANALYST AND INVESTOR CALL

pdf

Eris Lifesciences Ltd.

11 Aug 2022

1675.80

3.57%

Earnings Call

Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Dear Sir/Madam, Kindly note that the transcript of the Analyst and Investor call which was held after the announcement of financial results for the quarter ended 30 June 2022 is available on our website URL https://eris.co.in/financials/ (File name: Transcript of the Analyst and Investor Conference Call Q1FY23). Thanking You,

pdf

Eris Lifesciences Ltd.

10 May 2022

1675.80

3.57%

Earnings Call

Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

TRANSCRIPT OF ANALYST AND INVESTOR CALL

pdf

Eris Lifesciences Ltd.

04 May 2022

1675.80

3.57%

Earnings Call for Q4FY22 of Eris Lifesciences

Conference Call with Eris Lifesciences Management and Analysts on Q4FY22 Performance and Outlook. Listen to the full earnings transcript.

Eris Lifesciences Ltd.

03 Feb 2022

1675.80

3.57%

Earnings Call

Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Dear Sir/Madam, This is to inform that the transcript of the Analyst and Investor call which was held after the announcement of financial results for the quarter and nine month ended 31st December, 2021 is available on our website URL https://eris.co.in/financials/ (File name: Transcript of the Analyst and Investor Conference Call-Q3FY22).

pdf

Eris Lifesciences Ltd. Conference Calls and Earnings Call Transcripts